Related Experiment Video
Updated: Dec 13, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[The tuberculosis in 2020: challenges and opportunities.]
Francisco Javier García Pérez1, Julio Ancochea Bermúdez1
1Servicio de Neumología. Hospital Universitario de la Princesa. Madrid. España.
Tuberculosis remains a global health crisis, especially multidrug-resistant strains. New molecular diagnostics and treatments like bedaquiline offer hope for effective tuberculosis control.
Area of Science:
- Public Health
- Infectious Diseases
- Molecular Diagnostics
Background:
- Tuberculosis (TB) remains a significant global health issue, causing over 1.6 million deaths in 2017.
- The rise of multidrug-resistant tuberculosis (MDR-TB) complicates treatment and eradication efforts.
- Existing challenges necessitate advancements in diagnostic and therapeutic strategies for TB control.
Purpose of the Study:
- To highlight the ongoing global impact of tuberculosis.
- To discuss the challenges posed by drug-resistant tuberculosis strains.
- To review recent advancements in TB diagnostics and treatment.
Main Methods:
- Introduction of rapid molecular diagnostic techniques for TB detection.
- Identification of genetic mutations conferring drug resistance.
- Incorporation of novel drugs like bedaquiline and delamanid into treatment regimens.
Main Results:
- Molecular techniques enable diagnosis within hours, including resistance profiling.
- Newer drugs offer shorter, more effective, and less toxic treatment options for resistant TB.
- Progress in diagnostics and therapeutics is crucial for combating TB.
Conclusions:
- Early clinical suspicion in vulnerable populations is key.
- Accurate, early diagnosis using molecular methods is essential.
- Short, oral treatment regimens combined with socioeconomic strategies are vital for future TB eradication.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders